This relationship between CD33 expression and CC-96191 activity is important because CD33 expressed on AML cells varies over 2-log-fold across individual patients, and often varies significantly within any given patient but, overall, is relatively limited, in particular on immunophenotypically immature subsets of AML cells [10,11]. The gene discussed is CD33; the disease is acute myeloid leukemia.